Conference abstractPublished 9 May 2022
A novel study on SARS-COV-2 virus associated bradycardia as a predictor of mortality-retrospective multicenter analysis
Hemet Global Medical Center, USA
Abstract
SARS-CoV2 has affected more than 73.8 million individuals. While SARS-CoV2 is considered a predominantly respiratory virus, we report a trend of bradycardia among hospitalized patients, particularly in association with mortality. The multi-center retrospective analysis consisted of 1053 COVID-19 positive patients from March to August 2020. A trend of bradycardia was noted in the study population. Absolute bradycardia and profound bradycardia was defined as a sustained heart rate 18, the odds of dying increased 1.048 times (95% CI [1.25–5.27]). The incidence of absolute bradycardia was found in 24.9% of the study cohort and these individuals were found to have a significant increase in mortality.
Subjects
CardiologyFollow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical and Experimental Cardiology
- SubjectCardiology
- BylineArticles whose byline prints “Sabina Kumar”
- BylineArticles whose byline prints “Umeh Chukwuemeka”
- BylineArticles whose byline prints “Christina Arcuri”
- BylineArticles whose byline prints “Sumanta Chaudhuri”
- BylineArticles whose byline prints “Rahul Gupta”
- BylineArticles whose byline prints “Mahendra Aseri”
- BylineArticles whose byline prints “Shivang Shah”
- BylineArticles whose byline prints “Pranav Barve”
